Eszter Fodor

At the end of September, the European Commission carried out a dawn raid at Sanofi, which is also active in the vaccine market. The inspection was accompanied by representatives of national competition authorities. The raid fits into the increasingly hard-line enforcement policy pursued by European competition authorities in the pharmaceutical sector in recent years — a trend that may also be followed by the Hungarian Competition Authority (GVH).